These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32269183)

  • 41. Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients' carcinoma death.
    Ito Y; Miyauchi A; Kihara M; Kudo T; Miya A
    Endocr J; 2016 Jul; 63(7):663-7. PubMed ID: 27097545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical challenges with calcitonin-negative medullary thyroid carcinoma: three case reports and a review of the literature.
    Jingzhu Z; Xiangqian Z; Ming G; Yi P; Jiadong C; Xinwei Y; Guangwei X
    Ann R Coll Surg Engl; 2022 Mar; 104(3):221-230. PubMed ID: 34767473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows.
    Censi S; Di Stefano M; Repaci A; Benvenuti T; Manso J; Pagotto U; Iacobone M; Barollo S; Bertazza L; Galuppini F; Benna C; Pennelli G; Plebani M; Faggian D; Colombo C; Fugazzola L; Mian C
    Front Endocrinol (Lausanne); 2021; 12():754565. PubMed ID: 34721303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of high performance liquid chromatography, radio immunoassay and electrochemiluminescence immunoassay for quantification of serum 25 hydroxy vitamin D.
    Jafri L; Khan AH; Siddiqui AA; Mushtaq S; Iqbal R; Ghani F; Siddiqui I
    Clin Biochem; 2011 Jul; 44(10-11):864-8. PubMed ID: 21570387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chromogranin A as tumor marker in medullary thyroid carcinoma.
    Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
    Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
    Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of circulating calcitonin: analytical aspects.
    Martinetti A; Seregni E; Ferrari L; Pallotti F; Aliberti G; Coliva A; Fracassi S; Bombardieri E
    Tumori; 2003; 89(5):566-8. PubMed ID: 14870789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
    Carter WB; Taylor RL; Kao PC; Heath H
    J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical performance of calcitonin and procalcitonin Elecsys
    Giovanella L; Fontana M; Keller F; Verburg FA; Ceriani L
    Clin Chem Lab Med; 2021 Mar; 59(4):743-747. PubMed ID: 33085633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?
    Cho KE; Gweon HM; Park AY; Yoo MR; Kim J; Youk JH; Park YM; Son EJ
    Asian Pac J Cancer Prev; 2016; 17(7):3357-62. PubMed ID: 27509975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma.
    Kratzsch J; Willenberg A; Frank-Raue K; Kempin U; Rocktäschel J; Raue F
    Clin Chem Lab Med; 2021 Oct; 59(11):1861-1868. PubMed ID: 34256421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
    Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
    Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcitonin as Biomarker for the Medullary Thyroid Carcinoma.
    Bae YJ; Schaab M; Kratzsch J
    Recent Results Cancer Res; 2015; 204():117-37. PubMed ID: 26494386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation, role in perioperative assessment, and clinical applications of an immunoradiometric assay for human calcitonin.
    Wimalawansa SJ; Bailey F
    Peptides; 1995; 16(2):307-12. PubMed ID: 7784260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
    Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
    Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
    Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
    Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
    Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
    BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.